FREMONT, Calif., Feb. 24, 2025 /PRNewswire/ — Ultima Genomics, Inc., a developer of an ultra-high-throughput sequencing architecture, today announced the commercial launch of UG 100 Solaris at the ...
Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback